BCYC

Bicycle Therapeutics plc - ADR

3.69

USD

-0.08

-2.12%

Nov 10, 15:59 UTC -5

Closed

After-Market

3.69

0.00

-0.14%

Bicycle Therapeutics plc - ADR (BCYC) Profile

Bicycle Therapeutics plc - ADR Profile

About

Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.

Info & Links

CEO

Kevin Lee

Headquarters

BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON
CAMBRIDGE, X0 CB21 6GS, UNITED KINGDOM

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

288

Bicycle Therapeutics plc - ADR Statistics

Valuation Measures

Market Capitalization²

258.30M

Enterprise Value

-211.63M

Enterprise Value/EBITDA(ttm)

1.38

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.12

Price to Book(mrq)

0.52

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-169.75%

Profit Margin(ttm)

-3733.06%

Return on Equity(ttm)

-26.02%

Return on Invested Capital(ttm)

-26.21%

Return on Assets(ttm)

-22.30%

Income Statement

Revenue(ttm)

83.53M

Revenue Per Share(ttm)

1.19

Gross Profit(ttm)

83.53M

EBITDA(ttm)³

-153.62M

Net Income Available to Common(ttm)

-141.79M

Diluted EPS(ttm)

-2.03

Share Statistics

Beta (5Y Monthly)

1.59

52-Week Change

-42.70%

S&P 500 52-Week Change

16.37%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

70.09M

Dividend Yield

0.00%

Float⁴

54.59M

% Held by Insiders

22.00%

% Held by Institutions

86.15%

Balance Sheet

Total Cash(mrq)

469.93M

Total Cash Per Share(mrq)

6.70

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.09%

Quick Ratio(mrq)

12.09%

Book Value Per Share(mrq)

7.22

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.23

Free Cash Flow(ytd)

-157.12M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.